Robeco Institutional Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$437M Buy
3,459,893
+105,499
+3% +$13.9M 0.54% 35
2026
Q1
$468M Sell
3,354,394
-339,208
-9% -$47.5M 0.67% 23
2025
Q4
$453M Sell
3,693,602
-108,349
-3% -$13.2M 0.65% 22
2025
Q3
$422M Buy
3,801,951
+59,295
+2% +$6.74M 0.61% 23
2025
Q2
$415M Buy
3,742,656
+417,237
+13% +$44.4M 0.67% 22
2025
Q1
$373M Sell
3,325,419
-97,963
-3% -$10.1M 0.72% 24
2024
Q4
$316M Sell
3,423,382
-5,726
-0.2% -$516K 0.6% 31
2024
Q3
$287M Sell
3,429,108
-57,915
-2% -$4.42M 0.57% 32
2024
Q2
$239M Sell
3,487,023
-96,067
-3% -$6.41M 0.51% 37
2024
Q1
$262M Sell
3,583,090
-16,317
-0.5% -$1.25M 0.57% 33
2023
Q4
$292M Sell
3,599,407
-145,089
-4% -$11.3M 0.71% 29
2023
Q3
$281M Sell
3,744,496
-111,284
-3% -$8.56M 0.75% 21
2023
Q2
$297M Sell
3,855,780
-8,494
-0.2% -$677K 0.78% 16
2023
Q1
$321M Buy
3,864,274
+196,051
+5% +$16.2M 0.87% 15
2022
Q4
$315M Buy
3,668,223
+27,383
+0.8% +$2.17M 0.91% 13
2022
Q3
$225M Buy
3,640,840
+39,469
+1% +$2.49M 0.73% 27
2022
Q2
$223M Sell
3,601,371
-101,560
-3% -$6.29M 0.69% 30
2022
Q1
$220M Buy
3,702,931
+177,799
+5% +$11.4M 0.52% 41
2021
Q4
$256M Buy
3,525,132
+1,528,101
+77% +$105M 0.54% 45
2021
Q3
$139M Sell
1,997,031
-125,474
-6% -$8.82M 0.31% 86
2021
Q2
$146M Buy
2,122,505
+75,692
+4% +$5.05M 0.32% 80
2021
Q1
$132M Sell
2,046,813
-27,684
-1% -$1.79M 0.33% 84
2020
Q4
$121M Buy
2,074,497
+74,318
+4% +$4.48M 0.32% 81
2020
Q3
$126M Buy
2,000,179
+578,454
+41% +$40.1M 0.39% 64
2020
Q2
$109M Buy
1,421,725
+152,290
+12% +$11.7M 0.37% 65
2020
Q1
$94.9M Sell
1,269,435
-275,926
-18% -$19.1M 0.38% 58
2019
Q4
$100M Buy
1,545,361
+74,637
+5% +$4.86M 0.32% 72
2019
Q3
$93.2M Buy
1,470,724
+106,258
+8% +$6.95M 0.33% 69
2019
Q2
$92.2M Sell
1,364,466
-6,703
-0.5% -$441K 0.33% 71
2019
Q1
$89.1M Buy
1,371,169
+261,074
+24% +$17.4M 0.33% 71
2018
Q4
$69.3M Buy
1,110,095
+31,481
+3% +$2.2M 0.31% 79
2018
Q3
$83.3M Buy
1,078,614
+114,525
+12% +$8.65M 0.33% 80
2018
Q2
$68.3M Buy
964,089
+42,385
+5% +$2.99M 0.31% 88
2018
Q1
$69.5M Buy
921,704
+163,262
+22% +$13M 0.33% 86
2017
Q4
$54.3M Buy
758,442
+290,556
+62% +$22.1M 0.28% 98
2017
Q3
$37.9M Buy
467,886
+17,059
+4% +$1.3M 0.24% 116
2017
Q2
$31.9M Buy
450,827
+74,211
+20% +$4.94M 0.21% 135
2017
Q1
$25.6M Buy
376,616
+126,953
+51% +$8.93M 0.17% 156
2016
Q4
$17.9M Buy
249,663
+20,403
+9% +$1.52M 0.14% 187
2016
Q3
$18.1M Buy
229,260
+117,098
+104% +$9.51M 0.13% 190
2016
Q2
$9.36M Sell
112,162
-14,711
-12% -$1.31M 0.07% 256
2016
Q1
$11.7M Buy
126,873
+14,266
+13% +$1.29M 0.09% 222
2015
Q4
$11.4M Sell
112,607
-469,164
-81% -$48.8M 0.1% 222
2015
Q3
$57.1M Buy
581,771
+203,249
+54% +$22.6M 0.44% 65
2015
Q2
$44.3M Buy
378,522
+11,659
+3% +$1.27M 0.34% 90
2015
Q1
$36M Buy
366,863
+142,085
+63% +$14.4M 0.27% 109
2014
Q4
$21.2M Buy
224,778
+134,216
+148% +$13.9M 0.15% 173
2014
Q3
$9.64M Sell
90,562
-4,617
-5% -$452K 0.07% 259
2014
Q2
$7.89M Buy
95,179
+5,969
+7% +$465K 0.06% 268
2014
Q1
$6.32M Buy
89,210
+20,248
+29% +$1.59M 0.05% 280
2013
Q4
$5.18M Sell
68,962
-182
-0.3% -$12.7K 0.04% 282
2013
Q3
$4.34M Sell
69,144
-12,655
-15% -$756K 0.04% 290
2013
Q2
$4.19M Buy
+81,799
New +$4.26M 0.04% 291

Other funds holding GILD

Robeco Institutional Asset Management's GILD Position: Q2 2026 in Review

Robeco Institutional Asset Management increased its Gilead Sciences (GILD) stake by 3.1% in Q2 2026, buying an estimated $13.9M and bringing the position to 3,459,893 shares worth $437M. The position accounts for 0.54% of the portfolio, ranked #35.

Robeco Institutional Asset Management first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $468M in Q1 2026. 585 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Robeco Institutional Asset Management held 3,459,893 shares of Gilead Sciences worth $437M as of Q2 2026.
  • Robeco Institutional Asset Management bought 105,499 Gilead Sciences shares in Q2 2026, an estimated $13.9M.
  • Gilead Sciences made up 0.54% of Robeco Institutional Asset Management's portfolio in Q2 2026, its #35 holding.
  • Robeco Institutional Asset Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
  • Robeco Institutional Asset Management's Gilead Sciences position peaked at $468M in Q1 2026.
  • 585 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Robeco Institutional Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.